U.S. Professional Services Stock News

Why Banner stock is on investors’ radar With no single headline event setting the tone, Banner (BANR) is drawing attention through its banking franchise in the US Pacific Northwest and a mix of recent share price moves and fundamentals. See our latest analysis for Banner. At a latest share price of US$63.48, Banner’s recent momentum has been modest, with a 7 day share price return of 3.54% and a 90 day share price return of 5.08%. The 1 year total shareholder return of a 7.43% decline...

Synopsys (NasdaqGS:SNPS) has entered a collaboration with Lightmatter to integrate its advanced SerDes and UCIe IP into Lightmatter's 3D Co-Packaged Optics platform. The effort is aimed at supporting next generation AI infrastructure and high bandwidth connectivity between chips. For you as an investor, this sits at the intersection of Synopsys's core strengths in electronic design automation and the push toward faster, more energy efficient AI hardware. The focus on SerDes and UCIe IP...

If you are wondering whether Xcel Energy at around US$75.95 offers reasonable value today, you will want to see how its current price stacks up against several different valuation checks. The share price has had a mixed short term patch, with a 0.5% decline over the last 7 days, a 1.7% return over the last 30 days, and a 16.5% return over the past year. This gives some context for how the market currently prices the stock. Recent news around Xcel Energy has largely focused on ongoing...

If you are wondering whether Duke Energy's current share price lines up with its underlying worth, this article will walk through what the available data can and cannot tell you about value. Duke Energy's stock last closed at US$121.67, with returns of 1.1% over 7 days, 3.6% over 30 days, 3.6% year to date, 12.1% over 1 year, 35.9% over 3 years and 58.6% over 5 years. This provides useful context before looking at valuation. Recent news flow around Duke Energy has focused on ongoing interest...

If you are wondering whether Marathon Petroleum's current share price lines up with its underlying value, you are not alone. This article takes that question head on. The stock recently closed at US$187.58, with returns of 9.2% over 7 days, 13.6% over 30 days, 13.6% year to date, 22.2% over 1 year, 63.8% over 3 years and a very large gain over 5 years. Recent coverage of Marathon Petroleum has focused on how investors are reassessing large US refiners and fuel suppliers, paying close...

Wondering whether Opera's share price reflects its real worth, or if the market is missing something important about the business? You are looking at the right company for a valuation checkup. The stock closed at US$13.19, with a 4.7% decline over the last 7 days, a 7.3% decline over the last 30 days, a 7.3% decline year to date, a 23.2% decline over 1 year, but a 133.7% gain over 3 years and a 73.6% gain over 5 years. These mixed returns have kept Opera on the radar for investors who focus...

If you are wondering whether Equifax is priced attractively right now, this article will walk through what the market is paying for the stock and what that might mean for you. Equifax recently closed at US$199.17, with returns of a 7.1% decline over the past week, a 6.9% decline over the last month, a 6.9% decline year to date, and a 25.0% decline over the past year. These moves may have shifted how investors see its risk and potential. Recent coverage of Equifax has focused on its role as a...

Teva Canada entered an exclusive commercialization and supply agreement with Novartis Canada for Mayzent® for Canadian patients. The partnership focuses on continued access to Mayzent® for people living with secondary progressive multiple sclerosis in Canada. The arrangement relies on Teva Canada's national commercial network and central nervous system expertise to support ongoing supply. For investors following Teva Pharmaceutical Industries (NYSE:TEVA), this move expands the company’s...

F5 (NasdaqGS:FFIV) disclosed a high profile security breach involving alleged nation state actors. Following the disclosure, multiple law firms have announced or initiated class action lawsuits and investor investigations. The actions focus on allegations that F5 made misleading statements about its security posture and risk disclosures. F5, trading at $274.63, sits at the center of a material security and legal event that now extends beyond technical concerns into corporate accountability...

If you have ever wondered whether paying up for Ferrari stock still makes sense, this article will walk through what the current price might be implying about future expectations. Ferrari shares most recently closed at US$336.33, with returns of a 1.2% decline over the last 7 days, a 9.6% decline over the last 30 days, a 9.6% decline year to date, gains of 31.5% over 3 years and 66.6% over 5 years, and a 21.0% decline over the last year. Those mixed returns have kept interest in Ferrari...

Natural Resource Partners (NYSE:NRP) is close to becoming debt-free, following a period of strong free cash flow generation. The company has indicated that eliminating permanent debt could open the door to higher distributions to unitholders. NRP also holds a large portfolio of unleased carbon sequestration pore space that could offer additional long term growth options beyond its coal and royalty operations. Natural Resource Partners, trading at around $114.5, has posted very large 5 year...

LendingClub (NYSE:LC) has adopted the fair value option for its loan accounting, changing how it recognizes revenue and credit costs across its platform. The company is combining this accounting shift with Board and executive changes, including the planned resignation of its independent Chairman of the Board. LendingClub has also announced the upcoming departure of its Chief Risk Officer and outlined a leadership succession plan for the risk function. LendingClub enters these changes with...

Terns Pharmaceuticals (TERN) is back in focus after revising its agreement with Hansoh. The company has shifted to an exclusive, sublicensable, royalty-bearing, perpetual license for TERN-701 outside Greater China, alongside supportive interim Phase 1 data. See our latest analysis for Terns Pharmaceuticals. The agreement revision and positive interim Phase 1 data come after a sharp 90 day share price return of 102.42% and a very large 1 year total shareholder return. However, the 30 day share...

If you are wondering whether Trade Desk is starting to look interesting on price, you are not alone. This article focuses squarely on what you might be paying for each dollar of its business today. The stock recently closed at US$29.75, with returns of a 7.6% decline over 7 days, 21.0% decline over 30 days, 21.0% decline year to date and 73.8% decline over 1 year, as well as a 43.5% decline over 3 years and 65.6% decline over 5 years. These moves have played out alongside ongoing attention...

Wondering if APA at around US$25.89 is offering good value right now, or if the easy money has already been made. The stock has returned 1.9% over the last 7 days, 2.1% over the last 30 days and year to date, with a 26.8% return over 1 year, 31.0% over 3 years and 67.0% over 5 years. Together, these figures give you a mixed picture of recent momentum and longer term swings in sentiment. Recent coverage around APA has focused on how investors are reassessing energy names in light of commodity...

Genspark has adopted Twilio Programmable Voice to power its AI driven "Call for Me" agent. The integration uses NYSE:TWLO infrastructure to handle phone call based tasks in multiple languages. The partnership focuses on large scale, multilingual AI workflows that span both personal and enterprise use cases. For Twilio, the Genspark partnership puts a spotlight on its core communications platform as a tool for AI agents that have to operate over real world voice networks, not just text...

Annaly Capital Management recently reported its full-year 2025 results, with net income rising to US$2.03 billion and basic earnings per share from continuing operations increasing to US$2.92 from US$1.62 a year earlier, alongside strong Q4 performance across agency MBS, residential credit, and mortgage servicing rights. An interesting angle for investors is management’s plan to shift more capital toward residential credit and mortgage servicing rights while maintaining conservative leverage...

DaVita (NYSE:DVA) has partnered with Elara Caring and Ares' Private Equity Group to develop kidney specific home based care models. The collaboration focuses on expanding in home services for patients with complex and acute kidney needs. The partners aim to reduce preventable hospitalizations by tailoring care to dialysis and kidney disease patients where they live. DaVita enters this partnership with Elara Caring at a time when its shares trade around $111.19 and recent performance has...

Capital Clean Energy Carriers Corp. recently declared a US$0.15 per-share cash dividend for the fourth quarter of 2025, payable on February 12, 2026, to shareholders of record as of February 3, 2026. This payout comes as the company undertakes a US$3.00 billion fleet investment program to become a pure-play carrier of LNG, LPG, ammonia, and liquid CO₂, underscoring its commitment to energy-transition cargoes backed by long-term charters. We will now examine how this US$3.00 billion...

Casella Waste Systems recently reported year-on-year revenue growth and an earnings-per-share beat but missed adjusted operating income expectations and issued comparatively weaker full-year guidance. At the same time, institutional investors such as Baron Discovery Fund and ClearBridge Investments added Casella to their portfolios, highlighting its recurring revenue, acquisition-driven expansion, and concentration in less competitive rural markets. With recent results and new institutional...

Agilysys (AGYS) drew investor attention after raising its full year 2026 revenue outlook to US$318 million, alongside third quarter results that showed higher revenue and net income compared with the prior year period. See our latest analysis for Agilysys. Despite the upgraded revenue outlook and solid recent earnings updates, Agilysys’ share price has had a tougher run. It recorded a 7 day share price return of 21.4% and a 30 day share price return of 22.73%, while its 1 year total...

If you are wondering whether MasTec at around US$245.40 is offering good value or stretched pricing, you are not alone. This article is here to help you frame that question clearly. MasTec's share price has been steady over the last 7 days, with returns of 7.8% over the past month, 7.8% year to date, 73.3% over 1 year, 151.7% over 3 years and 196.0% over 5 years. This naturally raises questions about what is already reflected in the current price. Recent attention on MasTec has been shaped...

Perfect (PERF) has been drawing attention after recent share price weakness, with the stock around $1.52 and negative returns over the past year and past 3 months. This has prompted fresh scrutiny from investors. See our latest analysis for Perfect. Perfect’s recent share price return shows pressure building rather than easing, with a 7 day decline of 9%, a 30 day fall of 12% and a 1 year total shareholder return of 27% in the red, which points to fading momentum as investors reassess growth...

If you are wondering whether AngloGold Ashanti is still fairly priced after its strong run, this article will walk you through what the current share price might be implying about value. The stock recently closed at US$94.85, with returns of 10.8% over the last month and 219.4% over the past year. The 3 year and 5 year returns are 407.9% and 355.0% respectively, while the last 7 days have seen a 12.2% decline. Recent coverage of AngloGold Ashanti has highlighted investor interest in gold...